# Morgan Cheatham

> Morgan Cheatham is a seed investor at Breyer Capital (New York) backing LGBT and Medical. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Breyer Capital](https://shizune.co/investors/profile/breyer-capital)
- Location: New York, United States
- Total investments: 7
- Last investment: Jun 2026
- Lead investor: 43%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/morgan-cheatham-3b64a076/

Morgan Cheatham is a seed investor at Breyer Capital in New York focused on LGBT and Medical. Morgan Cheatham is the Head of health care and life sciences of Breyer Capital. Morgan Cheatham joined Bessemer Venture Partners in 2017 as an investor in the New York City office where he focuses on machine intelligence, healthcare, financial technology, and enterprise software.Before joining Bessemer, Morgan worked at Goldman Sachs in theConsumer Retail and Healthcare Group in the Investment Banking Division. He also worked as a data scientist at Kyruus, a healthcare IT startup focused on patient access and provider data management.Morgan graduated magna cum laude from Brown University with a Bachelor of Science in Neuroeconomics in the Liberal Medical Education Program. At Brown, he launched a retail investing app called Fello, which enables investors to create investment clubs with peers from their social networks. In his free time, Morgan enjoys practicing Tae Kwon Do, exploring the NYC music scene, and going to brunch.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| LGBT | 1 | 14% |
| Medical | 1 | 14% |
| Wellness | 1 | 14% |
| Biopharma | 1 | 14% |
| Health Care | 1 | 14% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 29% |
| Series A | 1 | 14% |
| Series B | 1 | 14% |
| Funding Round | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pathway Labs | Pathway Labs is a cardiology AI company. Its EchoNext software is an FDA cleared multi condition tool. It analyzes standard 12 lead ECGs to detect structural heart disease. The platform integrates into clinical workflows to coordinate patient care. | $8.5M | Seed | Jun 23, 2026 |  |
| ParcelBio | ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | $13M | Seed | May 07, 2026 |  |
| Folx Health | Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | $30M | Series B | Oct 12, 2022 |  |
| Folx Health | Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | $25M | Series A | Feb 02, 2021 |  |
| Folx Health | Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. | $4.4M | Seed | Dec 03, 2020 |  |
| Folx Health | Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. |  |  | Apr 21, 2020 |  |
| Folx Health | Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community. The platform builds a medical service marketplace tailored toward the queer community. It combines access to a specialized network of queer and trans clinicians with a tailored focus on clinical offerings that are typicallymarginalized in traditional health settings. The startup focuses on providing patients with gender-affirming hormone therapy, sexual health, and family creation services.Folx Health was launched in 2020 and is based in Boston, Massachusetts, United States. |  |  |  |  |

7 of 7 investments shown.

## Co-investors
- [Define Ventures](https://shizune.co/investors/profile/define-ventures) — VC Fund, 3 deals together
- [Polaris Partners](https://shizune.co/investors/profile/polaris-partners) — VC Fund, 2 deals together
- [7wire Ventures](https://shizune.co/investors/profile/7wire-ventures) — VC Fund, 1 deal together
- [AlleyCorp](https://shizune.co/investors/profile/alleycorp) — VC Fund, 1 deal together
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 1 deal together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 1 deal together

## About Breyer Capital

VC Fund · Menlo Park, United States

Breyer Capital is a premier global venture capital and private equity investor focused on catalyzing high-impact entrepreneurs in the United States and China. Founded by Jim Breyer in 2006, Breyer Capital makes long-term, idea-driven strategic investments in its chosen core areas: social media, entertainment/media, digital health, andfinancial technologies.Breyer Capital actively partners with a diverse set of companies including early-stage startups building breakthrough technologies, fast growing companies, and established worldwide leading corporations. Its team enjoys helping to frame strategic investments anchored by the passion of founders and owner/operator teams, the insights of its network of world-class investors, and a conviction that artificial intelligence, machine learning, and virtual reality will transform technology and investment opportunities globally.

4 contacts available at Breyer Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Daniel Breyer | Investor | https://shizune.co/investors/profile/daniel-breyer |
| Jim Breyer | Founder & CEO | https://shizune.co/investors/profile/jim-breyer |
| Leo Grady | CEO in Residence | https://shizune.co/investors/profile/leo-grady |
| Morgan Cheatham | Head of health care and life sciences | https://shizune.co/investors/profile/morgan-cheatham |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Morgan Cheatham invest in?

Morgan Cheatham invests primarily in LGBT, Medical and Wellness startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Morgan Cheatham last invest?

The most recent investment recorded for Morgan Cheatham closed in Jun 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co